Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

This study is ongoing, but not recruiting participants.

Study NCT00125463 Information provided by The Japanese Society of Hypertension

First Received: July 29, 2005 Last Updated: August 8, 2005 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2005
Estimated Primary Completion Date:	No date given

No publications provided by The Japanese Society of Hypertension

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ogihara T, Nakao K, Fukui T, Fukiyama K, Fujimoto A, Ueshima K, Oba K, Shimamoto K, Matsuoka H, Saruta T; CASE-J Trial Group. The optimal target blood pressure for antihypertensive treatment in Japanese elderly patients with high-risk hypertension: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial. Hypertens Res. 2008 Aug;31(8):1595-601.